STOCK TITAN

Acro Biomedical CEO Su resigns; Shih, Chen named

ACRO Biomedical announced the resignation of its chair/CEO and the same‑day appointment of a new chairman and combined CEO/CFO.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

ACRO BIOMEDICAL CO., LTD. (ACBM) reported significant leadership changes. On September 2, 2026, Yu‑Ting Su resigned as director, chairman and chief executive officer, effective upon the appointment of a successor, and the company stated this resignation did not result from any disagreement.

On the same date, the board appointed Shao‑Hsiang Shih as a director and chairman and Jing‑Zhou (Nick) Chen as chief executive officer and chief financial officer, both effective September 2, 2026. The filing details Mr. Shih’s administrative and education‑management background and Mr. Chen’s experience in digital platforms, cloud kitchens, gaming on blockchain, smart retail and semiconductor engineering.

Positive

  • None.

Negative

  • Chairman/CEO resignation: Yu‑Ting Su resigned as director, chairman and chief executive officer, creating a major leadership transition at the company.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Effective date of leadership changes September 2, 2026 Date when the chairman and CEO/CFO appointments became effective
Franchise locations led by new CEO Nearly 100 franchise locations Cloud‑kitchen franchise system expansion in Taiwan under Jing‑Zhou Chen at GBT Cloud Kitchen / Hongxi Enterprise Management
Service period at Century Publishing Co. 2010–2020 Director of Education Management; since 2020 Director of Administrative Management Professional history of new chairman Shao‑Hsiang Shih
Year of bachelor’s degree (new chairman) 2003 Shao‑Hsiang Shih’s graduation from the Department of Statistics at National Taipei University
Year of bachelor’s degree (new CEO/CFO) 2010 Jing‑Zhou Chen’s Bachelor of Science in Electrical Engineering from National United University
chief executive officer financial
"resigned as director, chairman and chief executive officer of the Company"
A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.
chief financial officer financial
"appointed Jing‑Zhou Chen as chief executive officer and chief financial officer"
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
cloud-kitchen franchise system technical
"he led the development and expansion of a cloud-kitchen franchise system in Taiwan"
short-form video platform technical
"operates a digital lifestyle and short-form video platform incorporating artificial"
blockchain technical
"a decentralized gaming platform developed on the EOS blockchain"
A blockchain is a digital record-keeping system that securely stores information across many computers, making it difficult to alter or tamper with. Think of it like a shared, unchangeable ledger that everyone can see and verify, ensuring transparency and trust. For investors, this technology offers a way to securely track transactions and assets without relying on a central authority, potentially reducing costs and increasing security.
cold-chain distribution technical
"established centralized food manufacturing and nationwide cold-chain distribution"

FAQ

What leadership changes did ACBM announce on September 2, 2026?

ACRO Biomedical disclosed that Yu‑Ting Su resigned as director, chairman and chief executive officer, effective upon appointment of a successor, and that Shao‑Hsiang Shih became chairman and director while Jing‑Zhou Chen became chief executive officer and chief financial officer, all effective September 2, 2026.

Did Yu-Ting Su resign from ACBM due to a disagreement with the company?

No. The company stated that Yu‑Ting Su’s resignation did not result from any disagreement with the company, indicating no reported dispute underlying the departure.

Who is the new chairman of ACRO Biomedical (ACBM) and what is his background?

The new chairman and director is Shao‑Hsiang Shih. He has held management roles at Century Publishing Co. since 2000 and previously at Century Education Center, and holds degrees from National Taipei University and Fo Guang University, with ongoing doctoral studies at Huafan University.

Who is the new CEO and CFO of ACRO Biomedical and what experience does he bring?

The board appointed Jing‑Zhou (Nick) Chen as chief executive officer and chief financial officer. His background includes leading Dream Born Co., Ltd., managing a cloud‑kitchen franchise, co‑founding a blockchain gaming platform, and earlier semiconductor engineering roles at Genes Tech and STATS ChipPAC Taiwan.

When did the new leadership appointments at ACBM become effective?

Both Shao‑Hsiang Shih’s appointment as director and chairman and Jing‑Zhou Chen’s appointment as chief executive officer and chief financial officer became effective on September 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 2, 2026

 

ACRO BIOMEDICAL CO., LTD.

 (Exact name of registrant as specified in Charter)

 

Nevada

 

333-207765

 

47-1950356

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File No.)

 

(IRS Employee

Identification No.)

 

12175 Visionary Way, Suite 1160; Fishers, Indiana 46038

(Address of Principal Executive Offices)

 

(317) 286-6788

(Registrant's Telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

    Written communications pursuant to Rule 425 under the Securities Act (I 7 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (I 7 CFR 240.14a-12(b))

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (I 7 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (I 7 CFR 240.13e-4(c))

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 2, 2026, Yu-Ting, Su resigned as director, chairman and chief executive officer of the Company, effective upon the appointment of a successor. Ms. Su's resignation did not result from any disagreement with the Company. 

 

On September 2, 2026, the Company's board of directors appointed Shao-Hsiang Shih as a director and as the Company's chairman, effective on September 2, 2026. Mr. Shao-Hsiang Shih has served as Director of Administrative Management at Century Publishing Co. since 2020. From 2010 to 2020, Mr. Shih served as Director of Education Management at Century Publishing Co. Prior to joining Century Publishing Co., he served as Director of Education Management at Century Education Center from 2000 to 2010. Mr. Shih graduated from the Department of Statistics at National Taipei University in 2003. He received a Master’s Degree from the Graduate Institute of Buddhist Studies at Fo Guang University in 2018. Since 2018, Mr. Shih has pursued doctoral studies at the Graduate Institute of Eastern Humanistic Thought at Huafan University.

 

On September 2, 2026, the Company's board of directors appointed Jing-Zhou Chen as chief executive officer and chief financial officer, effective on September 2, 2026. Mr. Nick (Jing-Zhou) Chen has served as Chief Executive Officer and founder of Dream Born Co., Ltd. since March 2025, where he is responsible for the company’s overall strategy, operations, business development and technology platform initiatives. Dream Born operates a digital lifestyle and short-form video platform incorporating artificial intelligence-based recommendation technology, consumer analytics, electronic vouchers and merchant revenue-sharing programs. From 2020 to 2025, Mr. Chen served as Chief Executive Officer and Managing Director of GBT Cloud Kitchen / Hongxi Enterprise Management, where he led the development and expansion of a cloud-kitchen franchise system in Taiwan. During his tenure, the business expanded to nearly 100 franchise locations and established centralized food manufacturing and nationwide cold-chain distribution capabilities. From 2018 to 2020, Mr. Chen was Co-Founder and Head of Operations of POKE25, a decentralized gaming platform developed on the EOS blockchain. From 2017 to 2018, he served as Vice President of Operations of G-Store Smart Retail Technology, where he was responsible for smart retail equipment deployment, mobile payment integration and franchise development in Taiwan. Earlier in his career, from 2011 to 2016, Mr. Chen worked in semiconductor process and equipment engineering with Genes Tech Co., Ltd. and STATS ChipPAC Taiwan. His responsibilities included semiconductor equipment integration, wafer-bumping production processes and quality-control systems, and he completed overseas assignments at semiconductor facilities in Shanghai, Singapore and Wuxi. Mr. Chen received a Bachelor of Science degree in Electrical Engineering from National United University in 2010. He is currently enrolled in the Executive MBA program in Information and Financial Management at National Taipei University of Technology, with studies focused on artificial intelligence, financial modeling, financial technology, corporate strategy and governance.

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 2, 2026  

ACRO BIOMEDICAL CO., LTD.

 

 

 

 

By:

/s/ Shao-Hsiang Shih

 

 

Shao-Hsiang Shih

 

 

 
3

 

Filing Exhibits & Attachments

5 documents